- ÃßÈÄ °³ÀÎÁ¤º¸ ¾÷µ¥ÀÌÆ®¸¦ À§ÇØ, ÀÔ·ÂÇϽŠID (À̸ÞÀÏ ÁÖ¼Ò)¿Í ÆÐ½º¿öµå¸¦ ¹Ýµå½Ã ±â¾ïÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
ID (À̸ÞÀÏ ÁÖ¼Ò) *
ÆÐ   ½º   ¿ö   µå *  (4~8ÀÚ ÀÌÇÏ ¿µ¹®À̳ª ¼ýÀÚÀÇ Á¶ÇÕ)
ÆÐ ½º ¿ö µå È® ÀÎ *
¼º         ¸í *
ȸ   »ç   ¸í *
ºÎ   ¼­   ¸í
Á÷         À§
¿ì Æí ¹ø È£ *
-
ȸ »ç ÁÖ ¼Ò *
»ó ¼¼ ÁÖ ¼Ò *
Àü         È­ *
- ¿¹) 02-508-4217
ÆÑ         ½º
- ¿¹) 02-508-4218
ÇÚ   µå   Æù * -
- ¸íÂû¿¡ º¸¿©Áú ³»¿ëÀÔ´Ï´Ù. ¿µ¹®À¸·Î ÀÛ¼ºÇÏ¿©Áֽñ⠹ٶø´Ï´Ù
Name (¼º¸í) *
First Name ¿¹) ±æµ¿ ¡æ Gil-dong
Last Name ¿¹) È« ¡æ Hong
Organization (¼Ò¼Ó) *
10. 8
(¼ö)
°³È¸½Ä & ±âÁ¶¿¬¼³
Micro/Nano-
biotechnology
Technology
Licensing
¹é½Å Ubiquitous
Healthcare
13:30-15:30

Micro/Nano-fluidics Technology
of UK/KOREA


13:30-15:00

Preparation of
Successful Licensing


13:30-14:30

Ưº°°­¿¬
Hepatitis C Virus



13:30-15:00

u-Health as Emerging Healthcare Service


15:50-17:50

Micro/Nano-biotechnology
of UK/KOREA I


15:20-16:50

Case Studies - Strategies for
Successful Technology Transfer


14:30-16:00

¾Ï¹é½ÅÀÇ ÇٽɼººÐ°ú
Ãֽŵ¿Çâ


16:20-17:50

¹é½Å°³¹ßÀÇ »õ·Î¿î
µ¿Çâ


15:20-16:50

Technologies and Applications for
u-Healthcare


10. 9
(¸ñ)
Biorefinery Micro/Nano-
biotechnology
Medical
Devices
½º¸¶Æ® ¾à¹°
Àü´Þ Àü·«
Business
Development
10:00-11:30

Processing of Lignocellulosic Biomass for Biorefinery


10:00-12:00

Micro/Nano-
biotechnology of UK/KOREA II


10:00-11:30

ÀÇ·á¿ë
ÀÓÇöõÆ®¸¦ À§ÇÑ »ýüÀûÇÕ¼ºÀç·á


10:00-11:30

¾à¹°Àü´Þ È¿À²ÀÇ
ÃÖÀûÈ­


10:00-11:00

Ưº°°­¿¬
Merck's Partnering
Strategy
in the Asia-Pacific
Region


11:00-12:30

Benchmarking Globally
Commercialized
Innovative Therapeutics
& Technologies


13:30-15:00

Microbial Catalysis
and Engineering


13:30-15:00

½ÉÇ÷°ü°è µð¹ÙÀ̽º


13:30-15:00

ÁúȯºÎÀ§·ÎÀÇ ¾à¹°
Àü´Þ Àü·«


13:30-15:00

Solutions to
Complicated Dilemmas of Funding-investment
Opportunities & Business
Development


15:20-16:50

Enzyme Catalysis
and Engineering


15:20-16:50

±Ù°ñ°Ý°è ÀÓÇöõÆ®


15:20-16:50

¾à¹°Àü´Þ ±â¼úÀÇ
ÃÖ±ÙÁøº¸


15:20-16:50

Technological
Innovation Strategy
for Biotechnology


10. 10
(±Ý)
Àç»ýÀÇÇÐÀÇ
ÃÖ±ÙÁøº¸
Regulatory
and GMP
Compliance
Therapeutic
Antibody
Botanical
New Drug
Development
Clinical Drug
Development
10:00-11:30

°æÁ¶Á÷ Àç»ýÀÇÇÐ
10:00-11:30

Regulatory Update
10:00-11:30

Recent Advances in
Therapeutic Antibody
R&D

10:00-11:30

õ¿¬¹° ¿¬±¸
°³¹ßÀü·«
10:00-11:30

Enhancing
Competitiveness
in Multinational Clinical
Trials
13:30-15:00

¿¬Á¶Á÷ Àç»ýÀÇÇÐ
13:30-15:00

GMP Compliance
13:30-15:00

Process Development of
Therapeutic Antibodies

13:30-15:00

õ¿¬¹° °³¹ß
¹× ¸¶ÄÉÆÃ
13:30-15:00

Clinical Trial Expert
Education and Training I
15:20-16:50

±Û·Î¹ú ¸¶ÄÏÀ» À§ÇÑ
ÃÖ±Ù »ó¿ëÈ­ µ¿Çâ
15:20-16:50

Quality Control
and Quality
Assurance
15:20-16:50

Forecasts by Industries in
Therapeutic Antibody
Development

15:20-16:50

õ¿¬¹° °³¹ß
ÇöȲ ¹× Àü¸Á
15:20-16:50

Clinical Trial Expert
Education and Training II
±¸ ºÐ
3ÀÏ ÆÐ½º
1ÀÏ ÆÐ½º
10¿ù 8ÀÏ 10¿ù 9ÀÏ 10¿ù 10ÀÏ
9¿ù 26ÀÏ ±îÁö 9¿ù 27ÀÏ ÀÌÈÄ
9¿ù 26ÀÏ ±îÁö 9¿ù 27ÀÏ ÀÌÈÄ
ÀÏ ¹Ý
88,000¿ø 110,000¿ø
44,000¿ø 55,000¿ø
´Ü Ã¼
44,000¿ø 55,000¿ø0
22,000¿ø 28,000¿ø
ÇР»ý
44,000¿ø 55,000¿ø0
22,000¿ø 28,000¿ø
Free Pass
   * ƼÄÏÀÇ ÀϷùøÈ£¸¦ ³Ö¾î ÁÖ¼¼¿ä.
µî·Ïºñ ÃѾ×:  ¿ø
¡Ø ÇлýÀÇ °æ¿ì, ÇлýÁõ »çº»À» À̸ÞÀÏ(bioconf@ibimp.com)À̳ª ÆÑ½º(02-508-4218)¸¦ ÀÌ¿ëÇÏ¿© ÄÁÆÛ·±½º »ç¹«±¹À¸·Î
¼ÛºÎÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
¡Ø ´ÜüÇÒÀÎÀº 20ÀÎ ÀÌ»óÀÌ µ¿½Ã¿¡ µî·ÏÇϽô °æ¿ì¿¡ ÇÑÇÕ´Ï´Ù.
- µî·Ï ½Åû ÈÄ, µî·Ïºñ ¿Ï³³ÀÌ ÀÌ·ç¾îÁ®¾ß µî·Ï󸮰¡ ¿Ï·áµË´Ï´Ù.
- ½Å¿ëÄ«µå °áÁ¦ ¼±Åà ½Ã ÆË¾÷À» Ç×»ó Çã¿ë(µµ±¸-ÆË¾÷ Â÷´Ü-ÆË¾÷ Â÷´Ü »ç¿ë ¾ÈÇÔ)À¸·Î º¯°æÇÏ¿© Áֽñ⠹ٶó¸ç,
Windows XP SP2 ÀÌ»óÀÇ OS¸¦ »ç¿ëÇϽô ºÐµé²²¼­´Â ½Å¿ëÄ«µå °áÁ¦ ½Ã â »ó´Ü¿¡ ³ë¶õ»ö ¹Ù°¡ ³ª¿À¸é
Active X ÄÁÆ®·Ñ ¼³Ä¡ Çã¿ëÀ» ¼±ÅÃÇØÁֽñ⠹ٶø´Ï´Ù.
°á Á¦ ±Ý ¾×
 ¿ø
°á Á¦ ¹æ ¹ý
- °è»ê¼­ÀÇ ¹ßÇàÀ» ¿øÇϽô ºÐÀº ¾Æ·¡¿¡ Ç¥½ÃÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
¿¹, ÇÊ¿äÇÕ´Ï´Ù.
¾Æ´Ï¿ä, ÇÊ¿äÇÏÁö ¾Ê½À´Ï´Ù.
- ¿µ¼öÁõÀÇ ¹ßÇàÀ» ¿øÇϽô ºÐÀº ¾Æ·¡¿¡ Ç¥½ÃÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
¿¹, ÇÊ¿äÇÕ´Ï´Ù.
¾Æ´Ï¿ä, ÇÊ¿äÇÏÁö ¾Ê½À´Ï´Ù.
- Âü¼®È®ÀÎÁõÀÇ ¹ß±ÞÀ» ¿øÇϽô ºÐÀº ¾Æ·¡¿¡ Ç¥½ÃÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
¿¹, ÇÊ¿äÇÕ´Ï´Ù.
¾Æ´Ï¿ä, ÇÊ¿äÇÏÁö ¾Ê½À´Ï´Ù.
   
ÄÁÆÛ·±½º & ºñÁî´Ï½ºÆ÷·³ : 02-508-4217\nÀü½Ãȸ : 02-6000-5118\nBIOKOREA 2008, 10.8 ~ 10.10, Osong Bio Technopolis\nCopyright BIO KOREA 2008.All Rights Reserved.